Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Scandella

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Vox Sanguinis|January 1, 1996
Human anti-factor VIII antibodies: epitope localization and inhibitory functionD Scandella
Vox Sanguinis|October 26, 1999
Epitope specificity and inactivation mechanisms of factor VIII inhibitor antibodiesD Scandella
Virology|April 1, 1974
An Escherichia coli mutant which inhibits the injection of phage lambda DNAD Scandella, W Arber
Virology|January 1, 1976
Phage lambda DNA injection into Escherichia coli pel- mutants is restored by mutations in phage genes V or HD Scandella, W Arber
Virology|July 1, 1976
Multiple steps during the interaction between coliphage lambda and its receptor protein in vitroM Roa, D Scandella
Seminars in Hematology|April 1, 1994
Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patientsL W Hoyer, D Scandella
The Journal of Biological Chemistry|June 9, 1995
A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factorE L Saenko, D Scandella
The Journal of Biological Chemistry|October 9, 1999
Human inhibitor antibodies specific for the factor VIII A2 domain disrupt the interaction between the subunit and factor IXaP J Fay, D Scandella
The Journal of Biological Chemistry|July 18, 1997
The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factorE L Saenko, D Scandella
Blood|September 15, 1993
A recombinant factor VIII A2 domain polypeptide quantitatively neutralizes human inhibitor antibodies that bind to A2D Scandella, M Mattingly, R Prescott
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Vox Sanguinis|January 1, 1996
Human anti-factor VIII antibodies: epitope localization and inhibitory functionD Scandella
Vox Sanguinis|October 26, 1999
Epitope specificity and inactivation mechanisms of factor VIII inhibitor antibodiesD Scandella
Virology|April 1, 1974
An Escherichia coli mutant which inhibits the injection of phage lambda DNAD Scandella, W Arber
Virology|January 1, 1976
Phage lambda DNA injection into Escherichia coli pel- mutants is restored by mutations in phage genes V or HD Scandella, W Arber
Virology|July 1, 1976
Multiple steps during the interaction between coliphage lambda and its receptor protein in vitroM Roa, D Scandella
Seminars in Hematology|April 1, 1994
Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patientsL W Hoyer, D Scandella
The Journal of Biological Chemistry|June 9, 1995
A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factorE L Saenko, D Scandella
The Journal of Biological Chemistry|October 9, 1999
Human inhibitor antibodies specific for the factor VIII A2 domain disrupt the interaction between the subunit and factor IXaP J Fay, D Scandella
The Journal of Biological Chemistry|July 18, 1997
The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factorE L Saenko, D Scandella
Blood|September 15, 1993
A recombinant factor VIII A2 domain polypeptide quantitatively neutralizes human inhibitor antibodies that bind to A2D Scandella, M Mattingly, R Prescott
Pageof 5